Updated on 1 November 2026
Life-science deployer wanted for the Deployment Catalyst: AI agents on GxP systems
Founder, Omphyr at Omphyr AI
london, United Kingdom
About
We’re an AI SME with a working control and evidence layer for AI agents acting on regulated systems (LIMS, QMS, ELN). Each action is checked against your policy before it runs, anything sensitive is held for a person’s sign-off, and a signed record shows who did what.
We’re looking for a UK manufacturer, CDMO or clinical organisation planning to put an AI agent to work on a regulated system in 2027, to form a consortium for the BridgeAI Deployment Catalyst. The pilot starts in observe mode, so nothing changes in your operation while the record is built. Deployment is in your own environment.
Stage
- Completing the consortia
Type
- Strategic Partnership
- Consortium seeks Partners
Organisation
Similar opportunities
Product
Control and evidence layer for AI agents in regulated life sciences
- Buyer
- Demonstration / Pilot projects
J Andrew
Founder, Omphyr at Omphyr AI
london, United Kingdom
Investment
Investment opportunity: operational assurance for enterprise AI agents
Armen Gevorkian
CEO at Armaxon / Lusinova
Wokingham, United Kingdom
Project cooperation
Governance partner for a BridgeAI Assurance and Compliance bid
- Technical
- Completing the consortia
- Technological contribution
- Drafting - writing the project proposal
Dylan Banks
Co-founder at Koralis AI
London, United Kingdom